tiprankstipranks
Rekah Pharmaceutical Industry Ltd. (IL:REKA)
TASE:REKA
Israel Market

Rekah (REKA) Financial Statements

0 Followers

Rekah Financial Overview

Rekah's market cap is currently ₪138.23M. The company's EPS TTM is -0.739; its P/E ratio is -6.91; Rekah is scheduled to report earnings on ―, and the estimated EPS forecast is ―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₪ 300.99M₪ 321.71M₪ 321.66M₪ 292.39M₪ 263.95M
Gross Profit₪ 58.17M₪ 71.95M₪ 80.20M₪ 78.70M₪ 65.16M
Operating Income₪ -6.26M₪ 16.37M₪ 2.96M₪ 13.25M₪ 14.14M
EBITDA₪ 24.51M₪ 47.30M₪ 26.03M₪ 40.73M₪ 35.77M
Net Income₪ -18.07M₪ 6.21M₪ -6.91M₪ -2.04M₪ 6.62M
Balance Sheet
Cash & Short-Term Investments₪ 4.38M₪ 7.07M₪ 19.35M₪ 20.29M₪ 18.64M
Total Assets₪ 423.68M₪ 447.22M₪ 484.72M₪ 448.42M₪ 437.09M
Total Debt₪ 132.39M₪ 134.16M₪ 178.90M₪ 154.38M₪ 165.82M
Net Debt₪ 128.05M₪ 127.13M₪ 159.59M₪ 134.17M₪ 147.22M
Total Liabilities₪ 279.47M₪ 285.24M₪ 329.14M₪ 286.34M₪ 264.02M
Stockholders' Equity₪ 144.16M₪ 161.93M₪ 155.54M₪ 162.03M₪ 173.01M
Cash Flow
Free Cash Flow₪ 5.92M₪ 17.84M₪ 16.86M₪ 31.52M₪ 7.17M
Operating Cash Flow₪ 12.95M₪ 26.54M₪ 28.35M₪ 39.00M₪ 21.17M
Investing Cash Flow₪ -6.29M₪ 15.29M₪ -21.50M₪ -13.45M₪ -35.90M
Financing Cash Flow₪ -9.37M₪ -54.13M₪ -7.78M₪ -24.36M₪ -2.78M
Currency in ILS

Rekah Earnings and Revenue History

Rekah Debt to Assets

Rekah Cash Flow

Rekah Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.